Home › Funds › Royce & Associates › FDMT
Royce & Associates position in FDMT
4D MOLECULAR THERAPEUTICS IN · Health Care
Latest position (Q4 2023)18.77K sh
Reported value held$380.26K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 9.30K | $204.00K | New |
| Q4 2023 | 18.77K | $380.26K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FDMT
- BlackRock Inc 4.55M sh · $60.46M · Q2 2026
- Goldman Sachs Group 4.26M sh · $56.64M · Q2 2026
- Janus Henderson Group 5.25M sh · $48.87M · Q1 2026
- Vanguard Group 3.09M sh · $23.20M · Q4 2025
- Geode Capital Management 1.13M sh · $15.01M · Q2 2026
- Bank of America Corp 1.12M sh · $14.90M · Q2 2026
- Citadel Advisors 901.20K sh · $11.99M · Q2 2026
- Deutsche Bank AG 710.94K sh · $9.46M · Q2 2026
- Renaissance Technologies 614.57K sh · $8.17M · Q2 2026
- Northern Trust Corp 562.93K sh · $7.49M · Q2 2026
- Morgan Stanley 503.02K sh · $6.69M · Q2 2026
- JPMorgan Chase & Co 402.14K sh · $5.18M · Q2 2026